SynthesisBiomolecules2023

An Overview of the Safety Profile and Clinical Impact of CDK4/6 Inhibitors in Breast Cancer-A Systematic Review of Randomized Phase II and III Clinical Trials.

Ioana-Miruna Stanciu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.